JP2024522304A5 - - Google Patents
Info
- Publication number
- JP2024522304A5 JP2024522304A5 JP2024518956A JP2024518956A JP2024522304A5 JP 2024522304 A5 JP2024522304 A5 JP 2024522304A5 JP 2024518956 A JP2024518956 A JP 2024518956A JP 2024518956 A JP2024518956 A JP 2024518956A JP 2024522304 A5 JP2024522304 A5 JP 2024522304A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- alkyl
- compound according
- cancers
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163196744P | 2021-06-04 | 2021-06-04 | |
| US63/196,744 | 2021-06-04 | ||
| PCT/US2022/032203 WO2022256680A1 (en) | 2021-06-04 | 2022-06-03 | Pyridopyrimidine derivatives useful as wee1 kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522304A JP2024522304A (ja) | 2024-06-13 |
| JP2024522304A5 true JP2024522304A5 (enExample) | 2025-06-10 |
Family
ID=82321319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518956A Pending JP2024522304A (ja) | 2021-06-04 | 2022-06-03 | Ｗｅｅ１キナーゼ阻害剤として有用なピリドピリミジン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240254123A1 (enExample) |
| EP (1) | EP4347592A1 (enExample) |
| JP (1) | JP2024522304A (enExample) |
| KR (1) | KR102997319B1 (enExample) |
| CN (1) | CN117794932A (enExample) |
| AU (2) | AU2022287033B2 (enExample) |
| CA (1) | CA3225152A1 (enExample) |
| IL (1) | IL309037A (enExample) |
| MX (1) | MX2023014466A (enExample) |
| WO (1) | WO2022256680A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240158972A (ko) | 2022-03-07 | 2024-11-05 | 데비오팜 인터네셔날 에스 에이 | 소세포 폐암의 치료 방법 |
| EP4777102A1 (en) | 2023-09-14 | 2026-07-22 | Debiopharm International SA | Combination of a wee1 inhibitor and a pkmyt1 inhibitor |
| CN120189510A (zh) * | 2023-12-21 | 2025-06-24 | 北京哲源科技有限责任公司 | 一种并环化合物的应用 |
| TW202541810A (zh) | 2023-12-22 | 2025-11-01 | 瑞士商德彪製藥國際公司 | 治療實體腫瘤之方法 |
| WO2025186213A1 (en) | 2024-03-04 | 2025-09-12 | Debiopharm International S.A. | Combination of a wee1 inhibitor and a topoisomerase 1 inhibitor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030044406A1 (en) | 2001-03-02 | 2003-03-06 | Christine Dingivan | Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents |
| PE20080695A1 (es) * | 2006-04-27 | 2008-06-28 | Banyu Pharma Co Ltd | Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel |
| EP2817308B1 (en) * | 2012-02-23 | 2016-09-07 | AbbVie Inc. | Pyridopyrimidinone inhibitors of kinases |
| GB201306610D0 (en) * | 2013-04-11 | 2013-05-29 | Almac Discovery Ltd | Pharmaceutical compounds |
| GB201612095D0 (en) * | 2016-07-12 | 2016-08-24 | Almac Discovery Ltd | Pharmaceutical compounds |
| MX2020001235A (es) * | 2017-08-01 | 2020-07-20 | Recurium Ip Holdings Llc | Análogos de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona. |
| GB201800378D0 (en) * | 2018-01-10 | 2018-02-21 | Almac Discovery Ltd | Pharmaceutical compounds |
-
2022
- 2022-06-03 US US18/565,598 patent/US20240254123A1/en active Pending
- 2022-06-03 JP JP2024518956A patent/JP2024522304A/ja active Pending
- 2022-06-03 WO PCT/US2022/032203 patent/WO2022256680A1/en not_active Ceased
- 2022-06-03 CN CN202280054331.6A patent/CN117794932A/zh active Pending
- 2022-06-03 MX MX2023014466A patent/MX2023014466A/es unknown
- 2022-06-03 AU AU2022287033A patent/AU2022287033B2/en active Active
- 2022-06-03 EP EP22735735.7A patent/EP4347592A1/en active Pending
- 2022-06-03 CA CA3225152A patent/CA3225152A1/en active Pending
- 2022-06-03 KR KR1020247000364A patent/KR102997319B1/ko active Active
- 2022-06-03 IL IL309037A patent/IL309037A/en unknown
-
2025
- 2025-06-23 AU AU2025204724A patent/AU2025204724A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL309037A (en) | Pyridopyrimidine derivatives are useful as WEE1 kinase inhibitors | |
| ES2537352T3 (es) | Combinaciones de compuestos inhibidores de fosfoinositida 3-cinasa y agentes quimioterapéuticos, y metodos para su uso | |
| JP7014731B2 (ja) | 置換アミノプリン化合物、その組成物、及びそれらを用いた治療方法 | |
| TWI838350B (zh) | 抗癌劑 | |
| CN120285177A (zh) | Hdac抑制剂和pd-1抑制剂的组合疗法 | |
| JP6824906B2 (ja) | 併用療法 | |
| JP2015518894A5 (enExample) | ||
| CN109819649B (zh) | 氨基嘌呤化合物的固体形式及其使用方法 | |
| KR20130069603A (ko) | 종양 및 섬유증 질환 치료에서의 신규 병용 치료 | |
| JP2018534289A5 (enExample) | ||
| CN112533602A (zh) | Axl激酶抑制剂及其用途 | |
| RU2014142057A (ru) | Комплексная терапия | |
| CN112043702A (zh) | 用于联合治疗结直肠癌的喹啉类化合物 | |
| KR102904026B1 (ko) | 헤테로시클릭 단백질 키나제 억제제를 포함하는 제제 | |
| CN112218639A (zh) | 包含双氟烷基-1,4-苯并二氮杂*酮化合物的组合组合物和其使用方法 | |
| ES2685974T3 (es) | Derivados de cefalosporina para tratar el cáncer | |
| CN112236147A (zh) | 包含双氟烷基-1,4-苯并二氮杂*酮化合物的组合物和其使用方法 | |
| CN114340636A (zh) | 治疗方法 | |
| CN101484443A (zh) | 放射线治疗增强剂 | |
| CN106459011A (zh) | 作为抗肿瘤化合物的σ‑2受体配体药物缀合物、其合成方法及其用途 | |
| JP2019516728A (ja) | 抗がん組合せ治療 | |
| CN112043831A (zh) | 用于联合治疗乳腺癌的喹啉类化合物 | |
| JP7636322B2 (ja) | 癌を処置するためのマドラシン誘導体化合物、組成物およびこれらの使用 | |
| EP3973963A1 (en) | Quinoline derivatives for treatment of head and neck cancer | |
| WO2016205299A1 (en) | New crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol |